Area of research
Emergency Medicine · Infectious Diseases
Research interest
Research interests include HIV-related health complications and treatments, HIV Research and Treatment, HIV/AIDS drug development and treatment, and Long-Term Effects of COVID-19.
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19
Sex Differences in Long COVID
Statin Therapy as Primary Prevention for Persons With HIV: A Synopsis of Recommendations From the U.S. Department of Health and Human Services Antiretroviral Treatment Guidelines Panel
Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort
Social Determinants of Health and Risk for Long COVID in the U.S. RECOVER-Adult Cohort
Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort
A multiomics recovery factor predicts long COVID in the IMPACC study
Age‐Related Changes in the Clinical Picture of Long <scp>COVID</scp>
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury
Identification of a multi-omics factor predictive of long COVID in the IMPACC study
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study.
Primary Care Guidance for Providers Who Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America
2024 Update of the RECOVER-Adult Long COVID Research Index
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality
Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19
Post–Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) After Infection During Pregnancy
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
Low-dose naltrexone use for the management of post-acute sequelae of COVID-19
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants
Low-Dose Naltrexone use for the management of post-acute sequelae of COVID-19
Corrigendum to “Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study” [eBioMedicine 83 (2022) 104208]
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study